PFM Health Sciences’s Medtronic MDT Stock Holding History

PFM Health Sciences’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-213,796	Closed	-$20.5M	–	94
2025 Q4	$20.5M	Buy	+213,796	New	+$20.8M	2.05%	16

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFM Health Sciences's MDT Position: Q1 2026 in Review

PFM Health Sciences sold out of Medtronic (MDT) in Q1 2026, closing a stake of 213,796 shares — an estimated $20.5M sold.

PFM Health Sciences first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $20.5M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

PFM Health Sciences reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
PFM Health Sciences sold 213,796 Medtronic shares in Q1 2026, an estimated $20.5M.
PFM Health Sciences first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
PFM Health Sciences's Medtronic position peaked at $20.5M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.